Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement - Royalty Pharma ( NASDAQ:RPRX ) , Ascendis Pharma ( NASDAQ:ASND )
NEW YORK and COPENHAGEN, Denmark, Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc RPRX and Ascendis Pharma A/S ASND today announced that Royalty Pharma and Ascendis Pharma Bone Diseases A/S, a wholly-owned subsidiary of Ascendis Pharma A/S, has entered into a $150 million capped ...
| Ticker |
Sentiment |
Impact |
|
ASND
|
Neutral
|
10 %
|
|
RPRX
|
Somewhat Bullish
|
27 %
|
|
ABBV
|
Neutral
|
3 %
|
